ESR1 and cancer: Whereas 30.4% of cancer cases with normal WWOX staining showed negative or almost negative for estrogen receptors, 56.3% ER − tumors and less than 25% ER-positive (ER +) tumors exhibited low WWOX expression (Guler et al. 2009).